检索结果 - Li-e Lin
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 studyR... 由 Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong, Ruibin Huang, Shuye Wang, Zeping Zhou, Guolin Yuan, Meijuan Huang, Li-E Lin, Shifeng Lou, Yanping Song, Qingchi Liu, Hu Zhou, Heng Mei, Yu Hu
发表在 The Lancet Regional Health. Western Pacific (2024-06-01)获取全文
文件 -
4
Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China 由 Qiu-Yuan Xiang, Jing-Song Wu, Ling Huang, Zong-Kai Zou, Ting-Bo Liu, Zhi-Gang Peng, Li-E. Lin, Xiao-Lei Wei, Hong-Yu Zhang, Yun Lin, Guo-Wei Li, Yi-Rong Jiang, Hua Wang, Ke-Qian Shi, Rui-Ji Zheng, Zhi-Jun Han, Xiao Qiu, Wen-Yu Li, Ji-Hao Zhou
发表在 Frontiers in Oncology (2025-06-01)获取全文
文件 -
5
Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study 由 Ling Huang, Yong Yang, Zhenyu Zhao, Shengsheng Zhou, Jingsong Wu, Ning Wang, Fen Zhang, Keqian Shi, ChengPing Li, Xiaolei Wei, Hongyu Zhang, Yun Lin, Guowei Li, Hui Zhou, Hanguo Guo, Xinmiao Jiang, Xiaojuan Wei, Feili Chen, Sichu Liu, Caidi Lin, Zhanli Liang, Yilan Huang, Lu Pan, Hui Yang, Yirong Jiang, Yudan Wu, Shuqin Cheng, Huifang Yang, Xiaoqiang Zheng, Xinggui Chen, Xiaoliang Li, GuiNian Huang, Jihao Zhou, Zhigang Peng, Li-e Lin, Tingbo Liu, Wenyu Li
发表在 Discover Oncology (2025-07-01)获取全文
文件
